CJC-1295 + Ipamorelin — Research Compound (10 mg Total)

Dual Peptide Blend (GHRH Analog + Ghrelin Receptor Agonist) — Lyophilized
For Laboratory & In-Vitro Research Only
Not for Human or Veterinary Use

Classification & Composition

• Compound Name: CJC-1295 + Ipamorelin (Research Peptide Blend)

• CAS Numbers:
   • CJC-1295: 863288-34-0
   • Ipamorelin: 170851-70-4

• Form: Lyophilized powder

• Quantity: 10 mg per vial

• Composition per vial:
   • CJC-1295 — 5 mg
   • Ipamorelin — 5 mg

• Type: GHRH analog + Ghrelin receptor agonist

• Purity: ≥ 98 % (HPLC)

• Intended Use: Laboratory and in-vitro research only

Research-Only Description

This vial contains a dual peptide blend of CJC-1295, a growth hormone–releasing hormone (GHRH) analog, and Ipamorelin, a selective ghrelin receptor (GHSR) agonist, formulated for controlled in-vitro and preclinical studies.
Research has focused on the synergistic activation of the hypothalamic–pituitary–somatotropic axis, leading to pulsatile growth hormone (GH) and insulin-like growth factor-1 (IGF-1) signaling under laboratory conditions.
Investigations have explored their combined influence on cellular metabolism, protein synthesis, and recovery mechanisms while maintaining normal feedback regulation of GH secretion.
Each vial is lyophilized to preserve peptide stability during transport and controlled storage.
This compound is offered exclusively for scientific and educational research applications.

Handling & Storage

Store in a cool, dry location away from direct light.
All handling and reconstitution should be performed only by trained professionals in a laboratory setting under sterile conditions.